This announcement is a separate document:
罗欣药业：2024年一季度报告
Luoxin Pharmaceuticals Group Stock: 2024 First Quarter Report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.